Collaborating to Advance Clinical Trial Diversity

Oregon Convention Center 

FDA Office of Minority Health and Health Equity (OMHHE) has continued its unwavering commitment and effort to support diverse participation in clinical trials through communications, policies, and advancing scientific research initiatives. In 2021, OMHHE established the Enhance Equity Initiative and created the office's first annual Health Equity Innovation Award funding opportunity to support research projects and communication resources to enhance 1) EQUITY in clinical trials by supporting efforts to advance diversity in clinical trials, 2) EQUITABLE data efforts by increasing research studies about diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and 3) EQUITY of voices by amplifying FDA's communication with diverse groups and to ensure stakeholders, including consumers, are informed about FDA's efforts and to understand diverse patient perspectives, preferences and unmet needs. Additionally, OMHHE long-standing Diversity in Clinical Trials Initiative includes an ongoing multi-media, public education, and outreach campaign to help address some of the barriers preventing diverse groups from participating in clinical trials,